Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded 'Hepatocellular carcinoma' as a disease term on the page. Updated the page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedGastric cancer added as a condition for the study. Resources section now includes a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision: v3.4.2 is displayed. The prior government-funding operating-status notice has been removed; core study details remain unchanged.SummaryDifference0.4%

- Check54 days agoChange DetectedA site-wide funding/status notice was added and the site version updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page updates add a Show glossary option, adjust labeling for QC status, and update footer/version text related to No FEAR Act and revisions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.